TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TRAW TRAWS PHARMA

Not Yet Opened 06-24 16:00:00 EDT

0.8610

+0.0235

+2.81%

盘后0.8404

-0.0206-2.39%

19:48 EDT

High0.8918	Low0.8300	Vol102.09K
Open0.8610	D1 Closing0.8375	Amplitude7.38%
Mkt Cap13.04M	Tradable Cap8.92M	Total Shares15.15M
T/O86.89K	T/O Rate0.99%	Tradable Shares10.36M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":0.861,"timestamp":1782331200000,"preClose":0.8375,"halted":0,"volume":102090,"hourTrading":{"tag":"盘后","latestPrice":0.8404,"preClose":0.861,"latestTime":"19:48 EDT","volume":5233,"amount":4476.7718,"timestamp":1782344936826,"change":-0.0206,"changeRate":-0.023926,"amplitude":0.044367},"delay":0,"changeRate":0.02805970149253727,"floatShares":10358000,"shares":15150700,"eps":-1.520743,"marketStatus":"Not Yet Opened","change":0.0235,"latestTime":"06-24 16:00:00 EDT","open":0.861,"high":0.8918,"low":0.83,"amount":86893.6513377,"amplitude":0.073791,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.520743,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782374400000},"marketStatusCode":0,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":0.8375,"preHourTrading":{"tag":"盘前","latestPrice":0.8919,"preClose":0.8375,"latestTime":"09:06 EDT","volume":1815,"amount":1542.0517694999999,"timestamp":1782306389166,"change":0.0544,"changeRate":0.064955,"amplitude":0.085851},"postHourTrading":{"tag":"盘后","latestPrice":0.8404,"preClose":0.861,"latestTime":"19:48 EDT","volume":5233,"amount":4476.7718,"timestamp":1782344936826,"change":-0.0206,"changeRate":-0.023926,"amplitude":0.044367},"volumeRatio":0.206262,"impliedVol":1.6331,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TRAW","defaultTab":"news","newsList":[{"id":"2645022306","title":"Traws Pharma Says Updated Toxicology Data Being Developed on Influenza Prophylaxis Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022306","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645022306?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:23","pubTimestamp":1782131035,"startTime":"0","endTime":"0","summary":"Traws Pharma  said Monday it has started developing an updated toxicology data package for the planned phase 2a human influenza challenge study of tivoxavir marboxil in response to information requirements from the UK's Medicines and Healthcare Products Regulatory Agency.Traws said it expects to resubmit the updated data package to the MHRA during Q3 to enable the human challenge study to proceed and provide proof of concept data for the use of tivoxavir marboxil as an oral prophylaxis medicine.The company said it expects a formal response from the regulator within 30 days of the resubmission.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645021030","title":"BRIEF-Traws Pharma Provides Updated Guidance On Influenza Prophylaxis Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021030?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:46","pubTimestamp":1782128812,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Provides Updated Guidance On Influenza Prophylaxis ProgramJune 22 (Reuters) - Traws Pharma Inc TRAW.O:TRAWS PHARMA PROVIDES UPDATED GUIDANCE ON INFLUENZA PROPHYLAXIS PROGRAMTRAWS PH","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029139","title":"Traws Pharma targets 3Q 2026 MHRA resubmission to advance TXM Phase 2a influenza challenge study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029139","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029139?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:02","pubTimestamp":1782126127,"startTime":"0","endTime":"0","summary":"Traws Pharma outlined plans to resubmit an updated toxicology package to the UK MHRA in 3Q 2026 for tivoxavir marboxil.The filing targets clearance to start a Phase 2a human seasonal influenza challenge study in healthy volunteers; no clinical results have been presented.Management expects the updated package to address MHRA requirements, aiming to keep the prophylaxis program moving toward proof-of-concept readouts.MHRA feedback prompted additional preclinical safety work; a formal agency response is expected within 30 days of resubmission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval sy","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL4DjcB0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645674029","title":"Traws Pharma - Preparing Updated Toxicology Data for Mhra Tivoxavir Marboxil Phase 2a Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645674029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645674029?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645602964","title":"Traws Pharma - Company Expects Mhra Response Within 30 Days of Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2645602964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645602964?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029677","title":"Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029677?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029649","title":"Traws Pharma - Updated Data Package to Be Resubmitted to Mhra in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029649?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029615","title":"Traws Pharma - Company to Initiate Profiling of Additional Molecules for Influenza Treatment Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029615?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644083461","title":"Traws Pharma Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2644083461","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644083461?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:14","pubTimestamp":1781784840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAW/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 18, 2026 08:14 ET (12:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644888100","title":"Traws Pharma Inc : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2644888100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644888100?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:28","pubTimestamp":1781782086,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644108848","title":"Traws Pharma downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2644108848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644108848?lang=en_us&edition=fundamental","pubTime":"2026-06-18 19:27","pubTimestamp":1781782031,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes downgraded Traws Pharma (TRAW) to Neutral from Buy with a price target of $1, down from $8, after the compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-downgraded-to-neutral-from-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643019200","title":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2643019200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643019200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:13","pubTimestamp":1781547236,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, PaychexWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL6N42N0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LUV","ABNB","TRIP","DAL","COIW","MU","LCLN","SCCO","TRAW","COII","COYY","SPCX","CCL","ELTX","FCX","PSKY","SHAZ","XOMO","MARA","XOMX","OXY","NEM","NMRA","CONY","CMTL","DDOG","XOM","AAL","SNK","LXEO","BAND","RIOT","UAL","SPCU","MRAL","ABNY","MUU","RCL","COIN","FOXA","APA","PTCT","CVX","PTRN","HUT","CONI","NCLH","FISV","ICOI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643207803","title":"Traws Pharma Cut to Neutral From Buy by Ladenburg Thalmann","url":"https://stock-news.laohu8.com/highlight/detail?id=2643207803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643207803?lang=en_us&edition=fundamental","pubTime":"2026-06-16 00:20","pubTimestamp":1781540400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAW/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 15, 2026 12:20 ET (16:20 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208113","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208113","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208113?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:41","pubTimestamp":1781523717,"startTime":"0","endTime":"0","summary":"Reitar Logtech  shares were down 20% in Monday premarket activity, extending the previous session's 10% decline.Wing Yip Food  stock was down 19%, following a 1.4% loss in the previous session.Traws Pharma  shares were down nearly 19% after the company said its planned test of tivoxavir marboxil in a phase 2a study was deferred following a negative review of the program by the UK's Medicines and Healthcare Products Regulatory Agency.Everbright Digital  stock was down about 20%, following the previous session's 44% gain.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4212","TRAW","BK4009","EDHL","BK4007","BK4233","BK4129","RITR","WYHG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643208699","title":"BUZZ-U.S. STOCKS ON THE MOVE-Crypto stocks, Travel stocks, Micron","url":"https://stock-news.laohu8.com/highlight/detail?id=2643208699","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643208699?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:35","pubTimestamp":1781523308,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Crypto stocks, Travel stocks, MicronWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f545ea281336f88cf96cc80dcc7b9eb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL6N42N0WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRA","CVX","CONI","LUV","BAND","NEM","CONL","XOM","UAL","RIOT","FCX","NWMX","MUD","TRIP","AALG","RIO.UK","SCCO","HUT","TRAW","RCL","COIG","MULL","AAL","SPCX","CCL.UK","RIOX","BHP.AU","ABNB","SPCF","OXY","CCL","MU","PTRN","RIO.AU","XOMO","HUTG","APA","COIO","DAL","MAAY","PSKY","SPAL","MARA","FIAT","XOMX","COIA","COIN","NCLH","SPCU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270897","title":"Ladenburg Thalmann Downgrades Traws Pharma to Neutral From Buy, Price Target is $3","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270897","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270897?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:59","pubTimestamp":1781521147,"startTime":"0","endTime":"0","summary":"Ladenburg Thalmann Downgrades Traws Pharma to Neutral From Buy, Price Target is $3","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643527717","title":"Traws Pharma Delays Phase 2 Influenza Study After UK Regulatory Review; Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2643527717","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643527717?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:42","pubTimestamp":1781520148,"startTime":"0","endTime":"0","summary":"Traws Pharma (TRAW) said late Friday that it has deferred a planned Phase 2 human influenza challenge study of its experimental drug, tivoxavir marboxil, after receiving a negative review from the UK'","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643651274","title":"BUZZ-Traws Pharma slips after UK regulator derails key flu drug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643651274","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643651274?lang=en_us&edition=fundamental","pubTime":"2026-06-15 17:46","pubTimestamp":1781516805,"startTime":"0","endTime":"0","summary":"BUZZ-Traws Pharma slips after UK regulator derails key flu drug trial** Shares of Traws Pharma TRAW.O fall 17.2% to $1.06 premarket** Co late on Friday said it has delayed a mid-stage human trial of its influenza drug after the UK medicines regulator  gave it a negative review** The tivoxavir marboxil drug's planned human challenge study, which was reviewed by UK's Medicines and Healthcare Products Regulatory Agency , has been deferred** TRAW said it is advancing backup drug candidates that match the original drug's long-acting profile and antiviral strength, but without any mutagenic potential** In February, the U.S. FDA placed on clinical hold its investigational new drug application for tivoxavir marboxil, due to \"concerns with the mutagenicity data package\"** Co has cash runway extending to Q1 2027** As of last close, stock up 13.4% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N0RP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643215809","title":"Traws Pharma influenza challenge study deferred following MHRA review","url":"https://stock-news.laohu8.com/highlight/detail?id=2643215809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643215809?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:40","pubTimestamp":1781300411,"startTime":"0","endTime":"0","summary":"Traws Pharma (TRAW) announced that the planned test of tivoxavir marboxil in a Phase 2a human influenza challenge study has been deferred due to a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-influenza-challenge-study-deferred-following-mhra-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-influenza-challenge-study-deferred-following-mhra-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643132802","title":"Traws Pharma Provides Regulatory Update on Influenza Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2643132802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643132802?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:30","pubTimestamp":1781299800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nTUA5XV59T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trawspharma.com","stockEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":-0.4379},{"period":"3month","weight":-0.5813},{"period":"6month","weight":-0.3246},{"period":"1year","weight":-0.4597},{"period":"ytd","weight":-0.2588}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.179894},{"month":2,"riseRate":0.384615,"avgChangeRate":-0.08728},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.040526},{"month":4,"riseRate":0.230769,"avgChangeRate":-0.139367},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.053691},{"month":6,"riseRate":0.692308,"avgChangeRate":0.029464},{"month":7,"riseRate":0.25,"avgChangeRate":-0.019463},{"month":8,"riseRate":0.230769,"avgChangeRate":-0.120142},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.103896},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.080722},{"month":11,"riseRate":0.461538,"avgChangeRate":-0.058331},{"month":12,"riseRate":0.307692,"avgChangeRate":0.009577}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TRAWS PHARMA(TRAW) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TRAWS PHARMA(TRAW) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}